Autologous CD133(+) Cells as an Adjuvant to Below the Knee (BTK) Percutaneous Transangioplasty (PTA)
Condition: Peripheral Arterial Disease Interventions: Biological: G-CSF + CD133(+) cells; Biological: G-CSF; Procedure: percutaneous transluminal angioplasty (PTA); Biological: Placebo infusion Sponsor: Shanghai 10th People's Hospital Recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials